CS219863B2 - Method of making the 3,4-bis-substituted 1,2,5-oxadiazol-2-oxide - Google Patents

Method of making the 3,4-bis-substituted 1,2,5-oxadiazol-2-oxide Download PDF

Info

Publication number
CS219863B2
CS219863B2 CS819454A CS945481A CS219863B2 CS 219863 B2 CS219863 B2 CS 219863B2 CS 819454 A CS819454 A CS 819454A CS 945481 A CS945481 A CS 945481A CS 219863 B2 CS219863 B2 CS 219863B2
Authority
CS
Czechoslovakia
Prior art keywords
formula
group
process according
compound
bis
Prior art date
Application number
CS819454A
Other languages
Czech (cs)
English (en)
Inventor
Karl Schonafinger
Rudi Beyerle
Anton Mogilev
Helmut Bohn
Melitta Just
Piero A Martorana
Rolf-Eberhard Nitz
Original Assignee
Cassella Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Ag filed Critical Cassella Ag
Publication of CS219863B2 publication Critical patent/CS219863B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/08—1,2,5-Oxadiazoles; Hydrogenated 1,2,5-oxadiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Materials For Photolithography (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
CS819454A 1980-12-18 1981-12-17 Method of making the 3,4-bis-substituted 1,2,5-oxadiazol-2-oxide CS219863B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803047730 DE3047730A1 (de) 1980-12-18 1980-12-18 3,4-bis-substituierte 1,2,5-oxdiazol-2-oxide, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
CS219863B2 true CS219863B2 (en) 1983-03-25

Family

ID=6119497

Family Applications (1)

Application Number Title Priority Date Filing Date
CS819454A CS219863B2 (en) 1980-12-18 1981-12-17 Method of making the 3,4-bis-substituted 1,2,5-oxadiazol-2-oxide

Country Status (28)

Country Link
US (1) US4356178A (es)
EP (1) EP0054872B1 (es)
JP (1) JPS57123173A (es)
KR (1) KR880000543B1 (es)
AR (1) AR227697A1 (es)
AT (1) ATE10094T1 (es)
AU (1) AU542529B2 (es)
CA (1) CA1157019A (es)
CS (1) CS219863B2 (es)
DD (1) DD201897A5 (es)
DE (2) DE3047730A1 (es)
DK (1) DK150597C (es)
ES (1) ES8300101A1 (es)
FI (1) FI813666L (es)
GR (1) GR81375B (es)
HK (1) HK51385A (es)
HU (1) HU183751B (es)
IE (1) IE52034B1 (es)
IL (1) IL64563A (es)
NO (1) NO814045L (es)
NZ (1) NZ199272A (es)
PH (1) PH18051A (es)
PL (1) PL128564B1 (es)
PT (1) PT74129B (es)
RO (1) RO84099B (es)
SG (1) SG21285G (es)
SU (1) SU1093246A3 (es)
ZA (1) ZA818726B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507485A (en) * 1984-01-23 1985-03-26 Bristol-Myers Company 3,4-Disubstituted-1,2,5-oxadiazoles having histamine H2 -receptor antagonist activity
DE4217794A1 (de) * 1992-05-29 1993-12-02 Cassella Ag Phenylfuroxane
DE4218582A1 (de) * 1992-06-05 1993-12-09 Cassella Ag Pyridyl-1,2,5-oxadiazol-carbonamid-2-oxide
DE4218979A1 (de) * 1992-06-10 1993-12-16 Cassella Ag Pyrimidofuroxane
DE4220264A1 (de) * 1992-06-20 1993-12-23 Cassella Ag Phenyl-1,2,5-oxadiazol-carbonamid-2-oxide
DE4223800A1 (de) * 1992-07-20 1994-01-27 Cassella Farbwerke Mainkur Ag Verwendung von 1.2.5-Oxadiazol-2-oxiden zur Behandlung erektiler Dysfunktionen
DE4307105A1 (de) * 1993-03-06 1994-09-08 Cassella Ag Hydroxymethylfurazancarbonsäurederivate
US5460669A (en) * 1993-06-28 1995-10-24 Thiokol Corporation 3-nitramino-4-nitrofurazan and salts thereof
DE4401150A1 (de) * 1994-01-17 1995-07-20 Cassella Ag Furazancarbonsäurederivate
AU2006259368A1 (en) 2005-06-15 2006-12-28 Hydra Biosciences, Inc. Modulators of sperm hypermotility and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089867A (en) * 1976-11-11 1978-05-16 Texaco Inc. Preparation of diacylfurazan oxides

Also Published As

Publication number Publication date
US4356178A (en) 1982-10-26
KR830007596A (ko) 1983-11-04
DK150597B (da) 1987-04-06
NO814045L (no) 1982-06-21
PL234257A1 (es) 1982-08-02
PT74129A (de) 1982-01-01
ZA818726B (en) 1982-11-24
AU7855881A (en) 1982-06-24
RO84099A (ro) 1984-05-12
PT74129B (de) 1983-05-16
HU183751B (en) 1984-05-28
DE3047730A1 (de) 1982-07-15
EP0054872A1 (de) 1982-06-30
IE52034B1 (en) 1987-05-27
JPH0223551B2 (es) 1990-05-24
SU1093246A3 (ru) 1984-05-15
CA1157019A (en) 1983-11-15
PH18051A (en) 1985-03-13
IL64563A (en) 1985-02-28
GR81375B (es) 1984-12-11
DK533881A (da) 1982-06-19
EP0054872B1 (de) 1984-10-31
PL128564B1 (en) 1984-02-29
NZ199272A (en) 1984-03-16
ES508086A0 (es) 1982-10-01
FI813666L (fi) 1982-06-19
DK150597C (da) 1987-10-26
ES8300101A1 (es) 1982-10-01
AR227697A1 (es) 1982-11-30
HK51385A (en) 1985-07-12
IE812976L (en) 1982-06-18
SG21285G (en) 1985-09-13
DD201897A5 (de) 1983-08-17
KR880000543B1 (ko) 1988-04-13
DE3167001D1 (en) 1984-12-06
ATE10094T1 (de) 1984-11-15
JPS57123173A (en) 1982-07-31
IL64563A0 (en) 1982-03-31
RO84099B (ro) 1984-06-30
AU542529B2 (en) 1985-02-21

Similar Documents

Publication Publication Date Title
KR880001428B1 (ko) 치환된 3-아미노-시드논-이민의 제조방법
EP0023343B1 (de) Substituierte 3-Amino-sydnonimine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
CS219863B2 (en) Method of making the 3,4-bis-substituted 1,2,5-oxadiazol-2-oxide
US4265900A (en) N-Aryl-N'-imidazol-2-ylureas
EP0210474B1 (de) Substituierte 3-Amino-sydnonimine, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
JPS61291567A (ja) 新規な１，４−ジヒドロピリジン類
EP0327808B1 (de) Substituierte 3-Aminosydnonimine, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0687256B1 (de) Hydroxymethylfurazancarbonsäurederivate und ihre verwendung in der behandlung von kardiovaskulären erkrankungen
JPS6222771A (ja) ５−置換−６−アミノピリミジン誘導体、組成物および使用
KR0139201B1 (ko) 아미노벤젠술폰산 유도체
HU183750B (en) Process for preparing new 1,2,5-oxadiazol-2-oxides
DD209195A5 (de) Verfahren zur herstellung von 1,2,5-oxadiazol-3,4-dicarbonsaeurederivaten
EP0575782A1 (de) Phenyl-1,2,5-oxadiazol-carbonamid-2-oxide zur Behandlung von cardiovasculären Störungen, insbesondere von Erektionstörungen
US6028068A (en) Substituted 6H-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
KR880001429B1 (ko) 치환된 3-아미노-시드논-이민의 제조방법
US6313111B1 (en) Substituted 6H-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and pharmaceutical composition containing them
EP0877026B1 (en) Substituted 6-r-1,3,4-thiadiazine-2-amines, the use thereof as anaesthetising, cardiovascular and hypometabolic agents, and a pharmaceutical composition containing them
US3974164A (en) Reserpic acid derivatives
EP0471232A1 (de) 3-Dicyclohexylamino-sydnonimine, Verfahren zu ihrer Herstellung und ihre Verwendung
HU198182B (en) Process for producing 3-amino-dihydropyridine derivatives and pharmaceutical compositions comprising same